Jason P Rhodes sold $7.1M of Dyne Therapeutics (DYN)

Executed Apr 23, disclosed Apr 27, 4 days later.

Value, as filed

$7.1M

382,568 sh across 9 lots

Executed

Apr 23

the trade date, as filed

Disclosed

Apr 27

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason P Rhodes Director profile →

Jason P Rhodes (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Dyne Therapeutics, Inc. (DYN). The largest single filing was $65.2M of DYN (2,586,928 sh across 6 lots, as filed), executed Aug 13.

The name

DYN

Dyne Therapeutics, Inc. DYN · Healthcare · 31 filings in 24 months ticker →

Healthcare · Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscul…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason P Rhodes in DYN

DYNSALE Dyne Therapeutics, Inc. $65.2M
2,586,928 sh across 6 lots
Exec Aug 13
Filed Aug 17 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $17.9M
777,451 sh across 10 lots
Exec Jul 6
Filed Jul 8 · 5:35 PM ET DYNSALE Dyne Therapeutics, Inc. $10.7M
504,695 sh across 6 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $5.6M
267,760 sh across 9 lots
Exec Jun 23
Filed Jun 26 · 5:30 PM ET † DYNSALE Dyne Therapeutics, Inc. $1.7M
95,113 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $4.2M
226,067 sh across 3 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $16.3M
827,099 sh across 9 lots
Exec Apr 20
Filed Apr 22 · 5:30 PM ET